Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Scientists have shown that a drug approved to treat migraine headaches can also alleviate debilitating non-headache symptoms, such as fatigue, brain fog and blinding light sensitivity, that occur ...

A drug called ubrogepant, which is already used to treat migraines, has now been found to reduce the non-headache symptoms that often hit in the hours preceding a migraine itself – making it the ...

Ubrogepant, a drug approved for migraine treatment since 2019, can not only be far more effective if taken on the first pre-headache symptoms, a recent clinical trial has found, but according to ...

Fremanezumab was associated with a significantly greater reduction in monthly migraine days and symptoms of depression than placebo in patients with migraine and comorbid major depressive disorder ...

Pfizer’s Vydura has become the first oral CGRP antagonist recommended for routine use by the NHS to prevent episodic migraine attacks, after being rejected earlier this year as an acute treatment.

DEAR PEOPLE’S PHARMACY: I have had chronic migraines for over 18 years. To treat them, I have used most of the triptan migraine meds with varying degrees of success, along with Botox ...

Screen time may cause headaches and migraine attacks for some people. You may be able to prevent or reduce the frequency of screen headaches by taking more screen breaks, optimizing your screen ...

Migraine refers to a group of primary headache disorders marked by recurrent unilateral headache episodes. Migraine headache is often described as moderate to severe pulsating pain. Migraine can ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine.

Migraine is one of the most severe and debilitating brain disorders. Most scientists accept that it involves activation and sensitization of the trigeminovascular system, which includes the ...